CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study
Byeong Wook Cho, Seok Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae
Clin Mol Hepatol. 2017;23(1):51-56.   Published online 2017 March 16    DOI: https://doi.org/10.3350/cmh.2016.0053

Excel Download

Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study
Clinical and Molecular Hepatology. 2017;23(1):51-56   Crossref logo
Link1 Link2

Effect and Safety of Daclatasvir-Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b -Infected Patients on Hemodialysis
Therapeutic Apheresis and Dialysis. 2016;20(5):462-467   Crossref logo
Link1

Daclatasvir and asunaprevir treatment in patients with severe liver fibrosis by HCV genotype 1b infection: Real world data
Journal of Gastroenterology and Hepatology. 2017;   Crossref logo
Link1

Favorable efficacy of daclatasvir plus asunaprevir in treatment of elderly Japanese patients infected with HCV genotype 1b aged 70 and older
Journal of Medical Virology. 2016;89(1):91-98   Crossref logo
Link1

Relationships between serum asunaprevir concentration and alanine aminotransferase elevation during daclatasvir plus asunaprevir for chronic HCV genotype 1b infection
Journal of Medical Virology. 2015;88(3):506-511   Crossref logo
Link1

Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection
Clinical and Molecular Hepatology. 2016;22(2):259-266   Crossref logo
Link1 Link2

Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis
Hepatology Research. 2016;47(3):E120-E131   Crossref logo
Link1 Link2

Su1438 Low Abundant Pre-Existing Drug Resistant Variants in Genotype 1b HCV Patients Treated With Daclatasvir and Asunaprevir Dual Therapy
Gastroenterology. 2016;150(4):S1100   Crossref logo
Link1 Link2

Asunaprevir/daclatasvir
Reactions Weekly. 2016;1629(1):35-35   Crossref logo
Link1 Link2

Treatment of HCV patients on hemodialysis with daclatasvir and asunaprevir
Journal of Gastroenterology. 2016;52(1):125-126   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.